Today: 27 April 2026
Browse Category

Stock Market 20 December 2025

Siemens Energy India Share Price Today (ENRIN): Latest News, Broker Targets up to ₹4,000, and What to Watch as of 20 December 2025

Siemens Energy India Share Price Today (ENRIN): Latest News, Broker Targets up to ₹4,000, and What to Watch as of 20 December 2025

Siemens Energy India shares closed at ₹2,747 on December 19, down 3.25%, remaining below the 52-week high of ₹3,625. The company disclosed a 5% promoter-group shareholding reshuffle and released its analyst meet transcript, highlighting ongoing factory expansions and a rising order backlog. Multiple brokerages updated targets, mostly between ₹3,125 and ₹4,000.
20 December 2025
Bharti Airtel Stock Update (20 December 2025): Rights-Issue Call, Leadership Shuffle, Tariff-Hike Bets and Fresh Analyst Targets

Bharti Airtel Stock Update (20 December 2025): Rights-Issue Call, Leadership Shuffle, Tariff-Hike Bets and Fresh Analyst Targets

Bharti Airtel’s board approved a ₹15,740 crore final call on partly-paid shares, with payment due between 2 and 16 March 2026. Shares closed at ₹2,097.70 on NSE Friday, just below the 52-week high of ₹2,174.70. The move completes a rights issue from 2021 and is intended to strengthen the balance sheet. Investors are also watching for leadership succession developments.
InterGlobe Aviation (IndiGo) stock: CCI antitrust review, DGCA scrutiny, and fresh analyst targets on Dec 20, 2025

InterGlobe Aviation (IndiGo) stock: CCI antitrust review, DGCA scrutiny, and fresh analyst targets on Dec 20, 2025

InterGlobe Aviation (IndiGo) closed at ₹5,153.50 on the NSE on December 19, up 0.74% for the day but still down about 13% for the month after flight cancellations and regulatory scrutiny. The airline canceled roughly 4,500 flights in early December, prompting government intervention. India’s Competition Commission has begun an initial antitrust review into the disruption and fare increases.
20 December 2025
HDFC Bank Share Price Today: Stock Holds Near ₹986 as RBI Rate-Cut Cycle, IndusInd Stake Nod, and Fresh Analyst Targets Shape the Outlook (Dec 20, 2025)

HDFC Bank Share Price Today: Stock Holds Near ₹986 as RBI Rate-Cut Cycle, IndusInd Stake Nod, and Fresh Analyst Targets Shape the Outlook (Dec 20, 2025)

HDFC Bank closed near ₹986 on December 19, 2025, a few percent below its 52-week high of ₹1,020.5. The RBI approved HDFC group entities to hold up to 9.5% in IndusInd Bank for one year. HDFC Bank also raised $1 billion overseas via its GIFT branch, priced at 94 basis points over SOFR. Market capitalization stands near ₹15.1 lakh crore.
ICICI Prudential AMC Stock in Focus: Share Price, Post-IPO News, Broker Targets and 2025 Outlook (Dec 20, 2025)

ICICI Prudential AMC Stock in Focus: Share Price, Post-IPO News, Broker Targets and 2025 Outlook (Dec 20, 2025)

ICICI Prudential AMC debuted on December 19, 2025, closing at ₹2,576.20 on NSE and becoming India’s most valuable listed asset manager with a market cap near ₹1.28 lakh crore, surpassing HDFC AMC. The stock opened at ₹2,600 and hit a high of ₹2,663.40. Analysts flagged caution on further near-term upside after the strong listing. Markets remained closed on December 20.
20 December 2025
Tata Motors Passenger Vehicles (TMPV) Stock: Latest News, Share Price Drivers, Forecasts and Analyst Outlook (Dec 20, 2025)

Tata Motors Passenger Vehicles (TMPV) Stock: Latest News, Share Price Drivers, Forecasts and Analyst Outlook (Dec 20, 2025)

Tata Motors Passenger Vehicles Ltd closed at ₹352.65 on Dec 19, trading near the lower end of its recent range after the 2025 demerger. A SEBI filing confirmed TMPV’s 0.10% stake in Tata Capital was transferred to the commercial vehicle entity as part of the restructuring. Investors remain focused on strong India PV and EV demand, while JLR volatility continues to weigh on the stock.
Shriram Finance Ltd Stock News (Dec 20, 2025): MUFG’s ₹39,618 Crore Deal, Record High Rally, and What Analysts Forecast Next

Shriram Finance Ltd Stock News (Dec 20, 2025): MUFG’s ₹39,618 Crore Deal, Record High Rally, and What Analysts Forecast Next

Shriram Finance’s board approved a ₹39,618 crore ($4.4 billion) investment from Japan’s MUFG Bank for a 20% stake via preferential shares at ₹840.93 each. The deal includes two board seats for MUFG, pre-emptive rights, and a $200 million non-compete fee, pending shareholder approval. Shriram Finance shares hit a record high after the announcement.
20 December 2025
India Stock Market Today (20 December 2025): Nifty, Sensex Rebound, India VIX Hits Record Low, Rupee Surges — Key Cues for Monday

India Stock Market Today (20 December 2025): Nifty, Sensex Rebound, India VIX Hits Record Low, Rupee Surges — Key Cues for Monday

Nifty 50 closed Friday at 25,966.40, up 0.58%, and Sensex at 84,929.36, up 0.53%, snapping a four-day losing streak. India VIX hit a record low of 9.52. The rupee surged 97 paise to 89.27 per dollar, its strongest daily gain since May. GIFT Nifty futures pointed higher for Monday, while foreign and domestic investors were net buyers.
20 December 2025
Wilmar International (SGX:F34) Stock: Latest News, Q3 2025 Results, Analyst Forecasts and 2026 Outlook (Dec. 20, 2025)

Wilmar International (SGX:F34) Stock: Latest News, Q3 2025 Results, Analyst Forecasts and 2026 Outlook (Dec. 20, 2025)

Wilmar International closed at S$3.06 on Dec. 19, up 0.66%, with shares little changed year-to-date. The company reported a Q3 2025 net loss of US$347.7 million after paying a US$708.9 million penalty tied to an Indonesia Supreme Court ruling. Core net profit rose 71.6% to US$357.2 million. Wilmar expects to remain profitable for the full year.
20 December 2025
CapitaLand Investment Limited (SGX:9CI) Stock: Latest News, Price Action, Analyst Forecasts and Key Catalysts as of 20 December 2025

CapitaLand Investment Limited (SGX:9CI) Stock: Latest News, Price Action, Analyst Forecasts and Key Catalysts as of 20 December 2025

CapitaLand Investment shares closed at S$2.69 on Friday, up 1.89% with 12.17 million shares traded. The company placed 14 dormant US subsidiaries into voluntary liquidation, saying the move will not affect group earnings. CLI also granted 21,728 shares under its restricted share plan, with no awards to directors or controlling shareholders.
20 December 2025
Singapore Exchange Ltd (SGX: S68) Stock: Latest News, Dividend Growth Plan, and Analyst Forecasts as of Dec 20, 2025

Singapore Exchange Ltd (SGX: S68) Stock: Latest News, Dividend Growth Plan, and Analyst Forecasts as of Dec 20, 2025

Singapore Exchange shares closed at S$16.87 on Dec. 19, 2025, near the top of their 52-week range after November securities turnover rose 18% year-on-year to S$35.5 billion. Analyst consensus remains “Hold,” with a mean target price of S$16.98, while several brokers raised targets following strong trading data.
Singapore Stock Market Today (20 Dec 2025): STI Ends Week Flat Near 4,570 as Banks Hold Record Highs; 2026 Outlook Turns More Bullish

Singapore Stock Market Today (20 Dec 2025): STI Ends Week Flat Near 4,570 as Banks Hold Record Highs; 2026 Outlook Turns More Bullish

Singapore’s Straits Times Index slipped 0.02% to 4,569.78 on Friday, ending the week near multi-year highs as trading remained flat. Advancers outnumbered decliners 329 to 177, with S$2.1 billion in turnover. City Developments rose 4% while Yangzijiang Shipbuilding fell 2.9%. CapitaLand Integrated Commercial Trust was the most traded stock by volume.
20 December 2025
OCBC Stock Surges to Fresh Highs: Latest News, Dividend Outlook, and Analyst Forecasts as of Dec 20, 2025

OCBC Stock Surges to Fresh Highs: Latest News, Dividend Outlook, and Analyst Forecasts as of Dec 20, 2025

OCBC shares closed at S$19.55 on Dec 19 after opening at a record S$19.69, capping a strong week for Singapore’s second-largest bank. The stock is up about 17% in 2025, driven by rising wealth-management income and analyst upgrades. OCBC reported S$1.98 billion in third-quarter net profit, with record non-interest income. UOB lagged behind, while DBS also hit record highs.
20 December 2025
UOB Stock (SGX:U11) Outlook: Latest News, Dividend Updates and Analyst Forecasts (Dec 20, 2025)

UOB Stock (SGX:U11) Outlook: Latest News, Dividend Updates and Analyst Forecasts (Dec 20, 2025)

UOB shares closed at S$34.70 on Dec 19 after reports the bank is exploring options for its asset management arm, including a possible sale or partnership. Investor focus remains on UOB’s exposure to Greater China commercial real estate, with over 40% of its Hong Kong branch loans tied to property as of June 2025. UOB declined to comment on the asset management review.
20 December 2025
Wesfarmers (ASX:WES) Stock Update: Priceline Pharmacies Enter Administration, AI Push Accelerates, and Analysts See Limited Upside Into 2026

Wesfarmers (ASX:WES) Stock Update: Priceline Pharmacies Enter Administration, AI Push Accelerates, and Analysts See Limited Upside Into 2026

Fifty-four Priceline-branded pharmacies operated by Infinity Pharmacy Group have been placed into administration, with KPMG appointed as receiver. Wesfarmers shares closed at A$81.02 on December 19, up 0.5% for the day. The affected stores continue trading, with employees retained and paid. Over 400 other Priceline pharmacies are not impacted.
20 December 2025
Westpac (ASX:WBC) Share Price Today: Latest News, Dividend Update, Analyst Forecasts and 2026 Outlook (20 Dec 2025)

Westpac (ASX:WBC) Share Price Today: Latest News, Dividend Update, Analyst Forecasts and 2026 Outlook (20 Dec 2025)

Westpac closed at A$38.76 on Friday, up 1.33%, near the top of its 52-week range. The bank’s final dividend of 77 cents per share was paid on 19 December, bringing the full-year payout to A$1.53. Analyst targets remain below the current share price despite a 21% gain over 12 months. Mortgage earnings growth is slowing as funding costs rise.
National Australia Bank (ASX: NAB) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (20 December 2025)

National Australia Bank (ASX: NAB) Stock: Latest News, Analyst Forecasts, and 2026 Outlook (20 December 2025)

NAB shares closed at A$42.14 on Friday, up 0.84%, with a 52-week range of A$31.13 to A$45.25. Morgans and Goldman Sachs both rated NAB “Sell” in recent broker updates, citing valuation risks and below-consensus earnings forecasts. NAB raised fixed home loan rates by up to 0.20 points from 16 December. The bank also announced a JPY 18 billion subordinated note issue due 2040.
20 December 2025

Stock Market Today

  • Options Traders Reflect on Toughest Lessons Learned
    April 27, 2026, 3:59 PM EDT. Options traders discuss valuable insights gained from difficult experiences in the derivatives market. Trading options-contracts granting the right to buy or sell an asset at a set price-requires understanding complex risks. Many traders highlight the importance of discipline, managing losses, and resisting emotional decisions. These lessons often come after costly mistakes, underlining how quickly volatility and leverage can amplify losses. Industry voices stress education and strategy adjustments as key to survival and success in options trading.

Latest article

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

27 April 2026
Intellia Therapeutics reported its CRISPR drug lonvo-z cut hereditary angioedema attacks by 87% versus placebo in a late-stage trial, with 62% of treated patients attack- and therapy-free over six months. The company has started a rolling U.S. approval application. No serious adverse events were reported. Intellia shares fell 0.9% to $13.51 after initial gains.
U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

U.S. Energy Corp Stock Jumps as $285 Helium Deal Gives Big Sky a Buyer

27 April 2026
U.S. Energy Corp. signed a five-year helium sales deal with an unnamed global industrial gas company, securing a buyer for output from its planned Big Sky Carbon Hub in Montana. The contract covers up to 1.2 million cubic feet a month at a fixed $285 per thousand cubic feet, with inflation adjustments starting March 2028. U.S. Energy shares rose 20.8% to $1.12 on heavy volume. The agreement is “take-or-pay,” with the buyer handling pickup at the plant.
Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

Veradermics Stock Jumps After VDPHL01 Hair-Loss Pill Hits Trial Goals

27 April 2026
Veradermics shares rose 40% Monday after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial of 519 men. Patients taking the drug saw average hair count increases of 30.3 to 33.0 hairs per square centimeter over six months, compared to 7.3 for placebo. No treatment-related serious or heart-related adverse events were reported.
Go toTop